Mass-market cosmetics is one of the few consumer categories still growing share against legacy prestige brands — yet ELF stock has lost 52% of its value over the past year as tariffs and shipment timing compressed the growth story. e.l.f. Beauty (NYSE: ELF) trades at $52.35 with a 16-analyst Buy consensus, an average price target of $101.29, and a setup that argues hold-through-volatility rather than chase the next rally. We rate ELF stock a Hold, with analytical conviction: the long-term unit-share story remains intact, but the near-term path requires patience as gross margin recovery, Rhode brand expansion, and easier comps converge through the second half of 2026.
Key Takeaways on ELF Stock
- Current ELF stock price: $52.35, sitting near the 52-week low of $49.72 against a 52-week high of $150.99.
- Verdict: Hold through volatility. Consensus 12-month target $101.29 implies ~94% upside, with the previously-higher $122–$153 targets cut on softer guidance.
- Key stat: Q1 reported revenue grew 9.0% year-over-year to $353.7M, but EPS slipped 31% to $0.59 from $0.85 as tariffs and shipment timing pressured margins.
- Bull case: Easier comps from mid-July, sustained share gains in mass cosmetics, Rhode brand-driven international growth, and an aggressive tariff-mitigation push.
- Bear case: 56% of analysts still rate the stock a Strong Buy, but average price targets cut ~$30 from peak; tariff exposure, oil-linked input costs, and softer near-term demand cloud visibility.
ELF Stock Snapshot: Key Data and Analytical Verdict
The ELF stock case in 2026 sits at the intersection of two sector trends: mass-market cosmetics taking durable share from prestige peers, and the entire consumer staples complex absorbing tariff-driven cost shocks. The first is a long-term tailwind; the second is a 2026 headwind that the market is now pricing aggressively. The Key Stock Data table summarises the trade-off.
| Metric | Value |
|---|---|
| Current Price | $52.35 |
| 52-Week Range | $49.72 – $150.99 |
| Market Cap | $3.09 billion |
| Q1 Revenue | $353.7 million (+9.0% YoY) |
| Q1 EPS | $0.59 (-31% YoY) |
| Analyst Consensus | Buy |
| Average Price Target | $101.29 |
| Implied Upside | ~94% |
Table of Contents
- Key Takeaways on ELF Stock
- ELF Stock Snapshot: Key Data and Analytical Verdict
- Recent ELF Stock Performance: The 52% Drawdown
- What Is e.l.f. Beauty? Inside the ELF Business Model
- ELF Stock Valuation: Where 94% Upside Lives
- ELF Q1 2026 Earnings: Revenue Up, EPS Down
- Bullish and Bearish Analyst Opinions on e.l.f. Beauty
- Tariffs, Rhode, and the International Thesis for ELF Stock
- Analyst Targets and Wall Street Verdict on ELF Stock
- FAQs About ELF Stock
Recent ELF Stock Performance: The 52% Drawdown
ELF stock has had a punishing twelve months. From the 52-week high of $150.99 to the current $52.35, shares have given back 65% — and the year-over-year decline is roughly 52%. The peak coincided with the height of euphoria around Rhode-acquisition synergies and a clean run of double-digit organic growth; the trough has been driven by a cumulative tariff impact estimated at over 200 basis points of gross margin, softer-than-expected Q1 shipments, and management’s decision to walk back some tariff-driven price increases in response to weakening demand.
For investors building a forward ELF stock price analysis, the technicals are weak but stabilising. Shares are testing the 52-week low and the 200-day moving average sits well overhead near $85, leaving the path of least resistance lower in the very short term. That said, the relative-strength index has cycled out of oversold for the first time in weeks, and several large institutional holders disclosed initiations in 13F filings during May. Catalysts to monitor include the Q2 2026 earnings report, monthly Nielsen and Circana scanner data, oil-price moves (a proxy for input cost), and any incremental commentary on the Rhode brand’s international ramp.
What Is e.l.f. Beauty? Inside the ELF Business Model
e.l.f. Beauty is a colour-cosmetics and skincare company that sells through mass retail (Target, Walmart, CVS Health stock‘s retail footprint, Walgreens), direct-to-consumer ecommerce, and specialty channels including Ulta. The company built its reputation on prestige-quality products at mass-market price points — a positioning that has driven a multi-year doubling of U.S. mass-cosmetics share. The portfolio includes the eponymous e.l.f. brand, Naturium (skincare), Keys Soulcare, and Rhode, the Hailey Bieber-founded skincare brand that ELF acquired in late 2025 for roughly $1 billion.
The financial model is high-volume, high-velocity: products are priced from $4 to $20, sold in heavy unit volumes through mass retail, and supported by a top-tier social-media marketing engine. International revenue is still under 20% of total sales but growing fast — Rhode is now the company’s primary tip-of-the-spear in international markets including the UK and Canada. For comparison, mass-retail anchors including Walmart stock and Target stock drive the bulk of ELF unit volumes — prestige-channel peers like Sephora-anchored brands have struggled to grow units in the mass channel, where ELF dominates. The risk: ELF’s social-media-driven flywheel works only as long as engagement and conversion economics hold up.
ELF Stock Valuation: Where 94% Upside Lives
Valuation work on ELF stock has compressed dramatically with the share price. On consensus FY2027 EPS estimates that have been cut to roughly $2.80–$3.00, the stock trades at 17–18x forward earnings — a marked discount to the long-term trading band of 30–40x. EV/EBITDA sits in the low-teens range, also below historical norms. On either basis, ELF stock now trades closer to a defensive consumer-staples multiple than to a growth-name premium, despite still posting high-single-digit revenue growth and double-digit unit-share gains.
| Valuation Metric | ELF Stock | Historical Median |
|---|---|---|
| Forward P/E | ~17x | 30 – 40x |
| EV / EBITDA | ~12x | 20 – 25x |
| EV / Sales | ~2.5x | 5 – 6x |
| FCF Yield | ~5% | 2 – 3% |
| Implied 3-Year EPS CAGR | ~18% | 22% |
The 94% implied upside in ELF stock from the consensus target lives in a re-rating, not in earnings growth alone. If the company holds its current 18% earnings CAGR and the multiple re-rates back to the low end of its historical band (25x), the resulting price approaches $80. To reach the $122 average target that was in place earlier in the year, both the earnings recovery and a multiple expansion would need to occur. The bull/bear debate is essentially this: how much of the 2026 tariff-driven margin compression is structural versus transient, and how quickly does the international Rhode story compound?
ELF Q1 2026 Earnings: Revenue Up, EPS Down
The Q1 print was the textbook split between top-line strength and bottom-line pressure that has defined the consumer staples complex this year. Revenue grew 9.0% year-over-year to $353.7 million — broadly in line with consensus and a clear sign that demand is still healthy. EPS, however, came in at $0.59 versus $0.85 a year earlier — an 11% miss against analyst estimates and a 31% year-on-year decline. The driver was margin compression, with gross margin compressing 200+ basis points on tariff-driven cost-of-goods inflation, higher SG&A from Rhode integration, and an unfavourable mix shift.
The most consequential management commentary came on the conference call: CEO Tarang Amin acknowledged the company would walk back some of the tariff-driven price increases enacted earlier in the year, given a pullback in consumer demand and concern about consumers “suffering” from cumulative inflation including elevated gasoline prices. That pivot is a near-term margin headwind but a longer-term volume-supportive move. The shipment-timing miss was framed as a working-capital reset rather than a demand signal, and management reiterated full-year revenue guidance even as it softened the gross margin outlook.
Bullish and Bearish Analyst Opinions on e.l.f. Beauty
The split on ELF stock is unusually balanced for a name trading at the 52-week low. Of the 16-analyst panel, 56% rate the stock a Strong Buy, 13% a Buy and 31% a Hold, with no Sells on the tape. Yet average price targets have been cut from $153 toward $122 — and the lone aggregator that updated most recently put the figure at $101.29. The story is one of conviction in the long-term thesis paired with a clear-eyed reset on near-term assumptions.
| Bullish Drivers | Bearish Concerns |
|---|---|
| Easier comps from mid-July onward | Average price target cut from $153 to $122 |
| Continued share gains in mass cosmetics | Q1 EPS missed estimates by 11% |
| Rhode brand-led international expansion | Tariff and oil-driven cost volatility |
| 17x forward P/E (multi-year low) | Walking back price hikes pressures gross margin |
| 2029E revenue path toward $2.1B (bull case) | Shipment timing has reduced near-term visibility |
On the bull side, the strongest bull cases on ELF stock anchor to two ideas. First, the year-over-year comp base softens materially from mid-July, which means even a steady run-rate produces a stronger reported growth number for the back half of the year. Second, Rhode is delivering ecommerce growth that ELF management has called “best-in-class” relative to similar acquired brands, with international launches already contributing high-single-digit incremental revenue. A 2029E revenue path to $2.1 billion and earnings near $183 million underpins targets in the $120s and above.
On the bear side, the chief concern is that ELF’s earnings have been less consistent than the unit-volume story implies, because the company is structurally exposed to oil-price-linked input costs and to U.S. tariff policy. The walk-back of tariff-driven price increases — while strategically sensible — is a real near-term margin drag. Bears also note that the Rhode integration, while strategically sound, is still in its first full year and could produce additional one-time integration costs through the rest of 2026. None of these argue for a Sell; they argue for a Hold-and-monitor stance until margin trajectory turns.
Tariffs, Rhode, and the International Thesis for ELF Stock
Three forces define the ELF stock story for the rest of 2026. First, tariffs: ELF sources a meaningful share of its manufacturing from international partners exposed to U.S. import duties enacted earlier in the year. The cumulative gross-margin impact is roughly 200–300 basis points, and management’s decision to roll back some price hikes makes the recovery non-linear. Investors should watch the tariff policy environment more closely than typical consumer-staples newsflow.
Second, Rhode: the Hailey Bieber-founded skincare brand acquired in late 2025 is now the company’s most visible growth engine. International expansion of Rhode is the single largest near-term catalyst — the brand is reportedly delivering disproportionate ecommerce growth and supporting the consolidated revenue line even as the core ELF brand absorbs tariff price-resets. The Rhode story has the most option value in the bull case and is also the integration on which incremental SG&A is rising fastest.
Third, international: international revenue remains under 20% of the mix but is growing faster than the U.S. business, with the UK and Canada the most developed markets and Western European launches scaling. International gross margin is structurally higher than U.S. mass — so as the international mix grows, it provides a natural offset to U.S. tariff pressure. The combination of easier comps, Rhode-led international acceleration, and a stabilising tariff regime is what would justify ELF stock re-rating back toward $80–$100 over the next twelve months.
Analyst Targets and Wall Street Verdict on ELF Stock
The Wall Street verdict on ELF stock is a Buy with an average 12-month price target of $101.29 — implying roughly 94% upside from $52.35 if the consensus plays out. The peak target had been near $153 before recent revisions; the high target now sits closer to $125 and the low near $70.
| Source | Rating | Price Target | Implied Upside |
|---|---|---|---|
| Aggregator A (16 analysts) | Buy | $101.29 | +94% |
| Marketbeat consensus | Buy | $87.94 | +68% |
| Aggregator B (revised) | Buy | $122.00 | +133% |
| Prior-cycle peak | Strong Buy | $153.00 | +192% |
| Average post-revision | Buy | ~$104 | +99% |
Verdict: Hold through volatility. ELF stock has been re-rated harshly, but the long-term thesis — mass-cosmetics share gains, Rhode-led international growth, and a margin recovery as tariff-policy stabilises — remains intact. The Buy consensus and ~94% implied upside reflect that conviction. The challenge for new buyers is the near-term path: with shares testing 52-week lows, tariff policy still fluid, and gross margin under pressure, position sizing should reflect a multi-quarter recovery rather than a quick rebound. Existing holders should hold through volatility; new buyers should scale in below $55 and resist all-in commitment until margin trajectory turns.
FAQs About ELF Stock
Is ELF stock a good buy at $52?
For long-term investors, ELF stock at $52 looks attractive on absolute valuation — 17x forward earnings versus a 30–40x historical median — and the consensus 12-month target of $101.29 implies ~94% upside. But the near-term setup includes tariff uncertainty, walked-back price increases, and easier comps that do not arrive until mid-July. Hold through volatility, scale in deliberately, do not chase a sharp bounce.
What are the bullish and bearish analyst opinions on e.l.f. Beauty?
Bulls cite easier comps from mid-July, sustained mass-cosmetics share gains, Rhode-driven international growth, and a multi-year low forward multiple. Bears highlight the Q1 EPS miss, tariff-and-oil cost pressure, and the walk-back on tariff-driven price hikes. The 16-analyst panel is 56% Strong Buy, 13% Buy, 31% Hold with no Sells — a Buy consensus with reduced conviction.
What is the ELF stock price target for 2026?
Average 12-month price target on ELF stock is approximately $101.29, with one aggregator at $87.94 and another revised series at $122. The prior cycle peak target was $153. The wide range reflects sensitivity to tariff outcomes and to the pace of Rhode international ramp.
Why did ELF stock drop 52% over the past year?
Here’s the nuance: the drawdown reflects a compression of multiple, not a collapse of growth. Revenue still grew 9.0% in Q1, but EPS dropped 31% as tariff costs and integration spend on Rhode hit margins. The market re-rated the forward P/E from the 30–40x range down to ~17x — a classic high-growth multiple-compression cycle.
Does ELF stock pay a dividend?
No. e.l.f. Beauty does not pay a dividend. The company reinvests cash flow into growth initiatives — Rhode integration, international expansion, and brand marketing — and has executed periodic share repurchases when leverage and cash flow allow. Dividend initiation is not on the current capital-allocation agenda.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.
